Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine - 1 Aug 2021

Raturi Manish, Kusum Anuradha, Kala Mansi, Mittal Garima, Sharma Anita, Bansal Naveen

Abstract excerpt

The only effective way to provide individuals with herd immunity against the novel coronavirus [SARS-CoV-2] is to administer an effective vaccine that will help check the current pandemic status. In India, the central drugs standard control organization (CDSCO) has granted the emergency-use authorization [EUA] to three vaccines namely, Covishield (live vaccine, Oxford AstraZeneca, United Kingdom being...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Communicable Disease Control

Share to Forecasting

Share to Geography, Medical

Share to Immunization, Passive

Share to Pandemics

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 33971318
DOI: 10.1016/j.tracli.2021.05.003
PMCID: PMC8103771

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants.PMID 33971318Read ↗

Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read ↗

Functional Antibodies in COVID-19 Convalescent PlasmaSemantic proximity Read ↗

Dynamics of SARS-CoV-2-specific antibodies during and after COVID19: Lessons from a biobank in ArgentinaSemantic proximity Read ↗

Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsSemantic proximity Read ↗

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal AntibodiesSemantic proximity Read ↗

COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic reviewSemantic proximity Read ↗

Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)Semantic proximity Read ↗

SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPYSemantic proximity Read ↗

HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donorsSemantic proximity Read ↗

Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic StudiesSemantic proximity Read ↗

Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection despite transiently enhancing disease and lung pathologySemantic proximity Read ↗

Inflammatory Markers and Auto-Abs to Type I IFNs in COVID-19 Convalescent PlasmaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.